Back to Results
First PageMeta Content
Clinical medicine / Medicine / Cancer / Antineoplastic drugs / Cancer treatments / Signal transduction / Breast cancer / Macrolides / Eribulin / Halichondrin B / MTOR inhibitors / Eisai


EISAI AND PIQUR SIGN LANDMARK COLLABORATION AGREEMENT TO INVESTIGATE HALAVENĀ® (ERIBULIN) AND PQR309 IN HARD TO TREAT FORM OF BREAST CANCER Agreement will see eribulin used in combination with novel PI3K/mTOR inhibitor i
Add to Reading List

Document Date: 2016-02-17 03:09:52


Open Document

File Size: 86,70 KB

Share Result on Facebook
UPDATE